BTK 억제 활성을 갖는 피리미딘 및 피리딘 화합물을 사용하여 암 치료하는 방법

본 발명은, 부루톤 티로신 키나아제(BTK)의 억제제인 피리미딘 및 피리딘 화합물을 사용하는 암 치료의 방법을 제공한다. The invention provides pyrimidine compounds A225 and A250, which are inhibitors of Bruton's tyrosine kinase (BTK), for use in treating cancer....

Full description

Saved in:
Bibliographic Details
Main Authors GIMMI MCKIM CLAUDE, HUCK BAYARD R, GOODSTAL SAMANTHA M
Format Patent
LanguageKorean
Published 02.07.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:본 발명은, 부루톤 티로신 키나아제(BTK)의 억제제인 피리미딘 및 피리딘 화합물을 사용하는 암 치료의 방법을 제공한다. The invention provides pyrimidine compounds A225 and A250, which are inhibitors of Bruton's tyrosine kinase (BTK), for use in treating cancer.
Bibliography:Application Number: KR20187013350